479623-72-8

Upstream product

• 635307-35-6 (2S,3R,4R,5R,6R)-4,5-Bis-benzyloxy-6-benzyloxymethyl-2-((2S,3S,4S,5R,6R)-2,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-3-yloxy)-tetrahydro-pyran-3-ol 
• 61134-30-3 benzyl 3,4,6-tri-O-benzyl-α-D-mannopyranoside 
• 635307-24-3 (2S,4S,5R,6R)-4,5-Bis-benzyloxy-6-benzyloxymethyl-2-((2S,3S,4S,5R,6R)-2,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-3-yloxy)-dihydro-pyran-3-one 
• 479623-70-6 benzyl 3,4,6-tri-O-benzyl-O-(2-O-benzoyl-3,4,6-tri-O-benzyl-β-D-glucopyranosyl)-(1->2)-α-D-mannopyranoside 
• 479623-60-4 3,4,6-tri-O-benzyl-α-D-glucopyranose 1,2-(pent-4-enyl orthobenzoate) 
• 479623-61-5 Benzoic acid (2S,3S,4S,5R,6R)-2,4,5-tris-benzyloxy-6-benzyloxymethyl-tetrahydro-pyran-3-yl ester 
• 479623-58-0 3,4,6-tri-O-benzyl-β-D-mannopyranose 1,2-(benzyl orthobenzoate) 

Relevant academic research and scientific papers

Orthoester-based strategy for efficient synthesis of the virulent antigenic-1,2-linked oligomannans of Candida albicans

Orthobenzoates of glucose and mannose provide donor and acceptor partners to produce a disaccharide bearing a benzoyl group at the site where gluco to manno conversion is required, the inverted center being ready to function, iteratively, as the next acce